30 Participants Needed

Walnuts for Cardiovascular Health

FM
TD
Overseen ByTatiana Diacova, MS, RDN
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of California, Davis
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

If you are taking medications or supplements that affect metabolism or gut bacteria, like Metformin, statins, or antibiotics, you may need to stop them to participate in this trial. The protocol does not specify a washout period, but these medications are part of the exclusion criteria.

What data supports the effectiveness of the treatment 'Walnuts for Cardiovascular Health'?

Research shows that eating walnuts can help lower bad cholesterol (LDL) and total cholesterol, which are linked to heart disease. Regular walnut consumption is also associated with overall heart health benefits, making them a good addition to a heart-healthy diet.12345

Is walnut consumption safe for humans?

Walnut consumption is generally considered safe for humans and has been associated with various health benefits, including improved cholesterol levels and reduced blood pressure, which are important for heart health.15678

How does the walnut treatment for cardiovascular health differ from other treatments?

The walnut treatment is unique because it involves consuming walnuts, which are rich in polyunsaturated fatty acids and antioxidants, to improve heart health by lowering bad cholesterol and blood pressure. Unlike traditional medications, this approach uses a natural food source to target multiple cardiovascular risk factors simultaneously.56789

What is the purpose of this trial?

The purpose of this research is to test if eating walnuts will cause any changes in blood lipids (like good and bad cholesterol, for example) and levels of inflammation in the blood, as well as changes in the bacteria living in the gut.

Eligibility Criteria

This trial is for overweight and obese men and postmenopausal women aged between 45-70, with a BMI of 25.0-39.9 kg/m2 and higher levels of 'bad' cholesterol (LDL-C between 130-189 mg/dL).

Inclusion Criteria

I am 45-70 years old, overweight or obese, and have high LDL cholesterol levels.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1 week
1 visit (in-person)

Run-in

Participants undergo a 1-week run-in period to become accustomed to the study diet

1 week
1 visit (in-person)

Diet Intervention 1

Participants follow either a walnut or no-nut diet for 3 weeks

3 weeks
1 visit (in-person)

Washout

Participants undergo a 3-week washout period between diet interventions

3 weeks
1 visit (in-person)

Diet Intervention 2

Participants switch to the alternate diet (walnut or no-nut) for 3 weeks

3 weeks
1 visit (in-person)

Follow-up

Participants are monitored for changes in cardiometabolic biomarkers and gut microbiota

1 week

Treatment Details

Interventions

  • No-nut diet
  • Walnuts
Trial Overview The study is examining the effects of eating walnuts on heart health markers like good and bad cholesterol, inflammation in the blood, as well as gut bacteria compared to a no-nut diet.
Participant Groups
2Treatment groups
Active Control
Group I: No-nut dietActive Control1 Intervention
Participants will follow a no-nut diet for 3 weeks.
Group II: Walnut dietActive Control1 Intervention
Participants will consume 56 g of walnuts each day at home for 3 weeks.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, Davis

Lead Sponsor

Trials
958
Recruited
4,816,000+

Findings from Research

In a study involving 40 healthy participants aged 50 and older, consuming 43g of walnuts daily for 8 weeks significantly reduced non-HDL cholesterol and apolipoprotein-B levels, which are important markers related to heart disease risk.
Despite these positive changes in cholesterol levels, other factors such as fasting glucose, insulin, and markers of inflammation and endothelial function did not show significant changes, indicating that walnuts may specifically target lipid profiles without affecting other metabolic parameters.
Walnut-enriched diet reduces fasting non-HDL-cholesterol and apolipoprotein B in healthy Caucasian subjects: a randomized controlled cross-over clinical trial.Wu, L., Piotrowski, K., Rau, T., et al.[2022]
A systematic review and meta-analysis of 139 studies found that consuming tree nuts and peanuts significantly reduces several cardiovascular disease (CVD) risk factors, including LDL cholesterol, total cholesterol, and triglycerides.
Despite the positive findings, the overall quality of evidence was low for many outcomes, indicating that while nuts can contribute to CVD risk reduction, further high-quality research is needed to confirm these benefits.
Tree Nut and Peanut Consumption and Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Houston, L., Probst, YC., Chandra Singh, M., et al.[2023]
A meta-analysis of 13 randomized controlled trials involving walnut intake showed significant reductions in total cholesterol (TC), low-density lipoprotein (LDL-C), and triglycerides (TG), indicating that walnuts can improve blood lipid profiles and potentially reduce cardiovascular disease risk.
The study found that individuals who were overweight or had comorbidities experienced greater improvements in lipid levels with walnut consumption, suggesting that walnuts may be particularly beneficial for these populations.
The Effect of Walnut Intake on Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Alshahrani, SM., Mashat, RM., Almutairi, D., et al.[2022]

References

Walnut-enriched diet reduces fasting non-HDL-cholesterol and apolipoprotein B in healthy Caucasian subjects: a randomized controlled cross-over clinical trial. [2022]
Walnut consumption and cardiac phenotypes: The Coronary Artery Risk Development in Young Adults (CARDIA) study. [2022]
Tree Nut and Peanut Consumption and Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [2023]
Effects of Supplementing the Usual Diet with a Daily Dose of Walnuts for Two Years on Metabolic Syndrome and Its Components in an Elderly Cohort. [2020]
The Effect of Walnut Intake on Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [2022]
Walnuts decrease risk of cardiovascular disease: a summary of efficacy and biologic mechanisms. [2023]
Replacing Saturated Fat With Walnuts or Vegetable Oils Improves Central Blood Pressure and Serum Lipids in Adults at Risk for Cardiovascular Disease: A Randomized Controlled-Feeding Trial. [2021]
Effects of walnut consumption on blood lipids and other cardiovascular risk factors: a meta-analysis and systematic review. [2023]
Antioxidant activity comparison of walnuts and fatty fish. [2012]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security